Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.85 |
| ▸ | TSHR | P16473 | 7/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30416074 | 1.00 | TDP1 (0.85) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL6062602 | 0.94 | TDP1 (0.76) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL6063097 | 0.94 | TDP1 (0.76) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| Ethylene Glycol SCHEMBL432445 | 0.94 | TDP1 (0.76) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL6061655 | 0.94 | TDP1 (0.76) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL12083356 | 0.92 | TDP1 (1.00) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL9765812 | 0.92 | TDP1 (0.92) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL11525680 | 0.91 | TDP1 (0.71) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL11530630 | 0.91 | TSHR (0.79) | TDP1TSHRLMNASERPINE1ALDH1A1 | |
| SCHEMBL10533481 | 0.91 | TDP1 (0.71) | TDP1TSHRLMNASERPINE1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-62149620-A | — | — | None | — | — | JP | disclosed |
| CN-122031446-A | External pharmaceutical composition containing loxoprofen and felbinac | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-122031449-A | External pharmaceutical composition containing loxoprofen and diclofenac | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-122031445-A | External pharmaceutical composition containing loxoprofen | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| EP-4615396-A1 | SUNSCREEN FORMULATION COMPRISING MICROCAPSULES, AND PROCESS FOR MANUFACTURING SUCH MICROCAPSULES | Exoshield (FR) | 2025-09-17 | — | — | EP | disclosed |
| CN-120035451-A | Nonaqueous percutaneous absorption preparation | 立德化学株式会社 | 2025-05-23 | — | — | CN | disclosed |
| CN-119947690-A | Oil-in-water type cosmetic | 株式会社黛怡茜 | 2025-05-06 | — | — | CN | disclosed |
| CN-114129544-B | Ultraviolet curable hydrogel resin for transdermal administration, hydrogel, and cataplasm comprising same | Icure药品株式会社 | 2025-03-21 | — | — | CN | disclosed |
| CN-119300811-A | High dose clomefene formulations and methods of use | 阿托萨治疗学公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-115135307-B | Cell delivery vehicle | 株式会社ITO | 2024-11-22 | — | — | CN | disclosed |
| WO-2007137128-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY, INC. (US) | 2007-11-22 | — | — | US | disclosed |
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY, INC. (US) | 2007-11-22 | — | — | US | disclosed |
| EP-1454958-B1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEM CO LTD (JP) | 2006-10-04 | — | — | EP | disclosed |
| US-20050001349-A1 | Lactic acid polymer composition and molded object thereof | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1454958-A1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2004-09-08 | — | — | EP | disclosed |
| EP-0445819-B1 | Positive type photoresist composition | FUJI PHOTO FILM CO LTD (JP) | 2001-08-22 | — | — | EP | disclosed |
| EP-0445819-A2 | Positive type photoresist composition | FUJI PHOTO FILM CO., LTD. (JP) | 1991-09-11 | — | — | EP | disclosed |
| JP-S62149620-A | ANALGESIC ANTIINFLAMMATORY FOR EXTERNAL USE | SHIONOGI & CO LTD | 1987-07-03 | — | — | JP | disclosed |
| EP-0148787-A2 | Positive type photosensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1985-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | GLA, GK, UNG | TDP1 892/4885TSHR 4802/4885LMNA 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.